Strides Pharma Science Statistics

Total Valuation

BOM:532531 has a market cap or net worth of INR 77.90 billion. The enterprise value is 94.98 billion.

Market Cap	77.90B
Enterprise Value	94.98B

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Current Share Class	92.16M
Shares Outstanding	n/a
Shares Change (YoY)	+1.12%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	56.80M

Valuation Ratios

The trailing PE ratio is 2.17 and the forward PE ratio is 16.27.

PE Ratio	2.17
Forward PE	16.27
PS Ratio	1.71
PB Ratio	3.01
P/TBV Ratio	5.42
P/FCF Ratio	17.63
P/OCF Ratio	11.38
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.80, with an EV/FCF ratio of 21.49.

EV / Earnings	2.64
EV / Sales	2.08
EV / EBITDA	11.80
EV / EBIT	15.51
EV / FCF	21.49

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.73.

Current Ratio	1.20
Quick Ratio	0.54
Debt / Equity	0.73
Debt / EBITDA	2.34
Debt / FCF	4.25
Interest Coverage	2.45

Financial Efficiency

Return on equity (ROE) is 17.58% and return on invested capital (ROIC) is 8.43%.

Return on Equity (ROE)	17.58%
Return on Assets (ROA)	6.42%
Return on Invested Capital (ROIC)	8.43%
Return on Capital Employed (ROCE)	17.66%
Revenue Per Employee	14.90M
Profits Per Employee	11.72M
Employee Count	3,065
Asset Turnover	0.77
Inventory Turnover	1.65

Taxes

In the past 12 months, BOM:532531 has paid 775.16 million in taxes.

Income Tax	775.16M
Effective Tax Rate	15.92%

Stock Price Statistics

The stock price has decreased by -14.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.48%
50-Day Moving Average	712.59
200-Day Moving Average	942.50
Relative Strength Index (RSI)	62.84
Average Volume (20 Days)	48,801

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532531 had revenue of INR 45.65 billion and earned 35.93 billion in profits. Earnings per share was 390.50.

Revenue	45.65B
Gross Profit	25.85B
Operating Income	6.11B
Pretax Income	4.87B
Net Income	35.93B
EBITDA	8.03B
EBIT	6.11B
Earnings Per Share (EPS)	390.50

Full Income Statement

Balance Sheet

The company has 2.06 billion in cash and 18.80 billion in debt, giving a net cash position of -16.73 billion.

Cash & Cash Equivalents	2.06B
Total Debt	18.80B
Net Cash	-16.73B
Net Cash Per Share	n/a
Equity (Book Value)	25.86B
Book Value Per Share	276.93
Working Capital	5.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.84 billion and capital expenditures -2.42 billion, giving a free cash flow of 4.42 billion.

Operating Cash Flow	6.84B
Capital Expenditures	-2.42B
Free Cash Flow	4.42B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.63%, with operating and profit margins of 13.37% and 78.71%.

Gross Margin	56.63%
Operating Margin	13.37%
Pretax Margin	10.67%
Profit Margin	78.71%
EBITDA Margin	17.58%
EBIT Margin	13.37%
FCF Margin	9.68%

Dividends & Yields

This stock pays an annual dividend of 864.00, which amounts to a dividend yield of 97.80%.

Dividend Per Share	864.00
Dividend Yield	97.80%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	0.64%
Buyback Yield	-1.12%
Shareholder Yield	96.68%
Earnings Yield	46.13%
FCF Yield	5.67%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7